Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) has earned a consensus recommendation of "Buy" from the eight brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and three have issued a strong buy recommendation on the company.
Several research firms recently issued reports on RBGLY. Barclays lowered Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, February 4th. HSBC raised Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Wednesday, December 11th. Hsbc Global Res raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th.
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
Shares of Reckitt Benckiser Group stock traded down $0.01 during trading hours on Monday, reaching $13.32. The company had a trading volume of 209,875 shares, compared to its average volume of 308,963. Reckitt Benckiser Group has a one year low of $10.24 and a one year high of $14.10. The business has a fifty day simple moving average of $13.06 and a 200 day simple moving average of $12.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47.
Reckitt Benckiser Group Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be given a dividend of $0.2909 per share. The ex-dividend date of this dividend is Friday, April 11th. This is an increase from Reckitt Benckiser Group's previous dividend of $0.19.
About Reckitt Benckiser Group
(
Get Free ReportReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
